J Cook
Family Medicine · Chicago, ILNPI 1104814912
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $8,315 of the $9,306 with a category attached, or 89.4%. 28 manufacturers reported payments, led by Gilead at 26.5% of the total. Reporting peaked in 2021 at $2,919 and has fallen 88.6% since, to $333 in 2025. Among family medicine clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 477 payments — averaging $19.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$2K
- AbbVie$2K
- Novo Nordisk$1K
- Viiv Healthcare Company$705
- AstraZeneca$496
- Takeda Pharmaceuticals U.S.A., Inc.$390
- plus $2K from 22 others
What the payments were for
- Consulting fees$7308%
- Food & beverage$8,31589%
- Education$2603%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 98 | $2,470 |
| AbbVie(2 entities) | 105 | $2,011 |
| Novo Nordisk | 68 | $1,250 |
| Viiv Healthcare Company | 42 | $705 |
| AstraZeneca | 32 | $496 |
| Takeda Pharmaceuticals U.S.A., Inc. | 35 | $390 |
| Johnson & Johnson(2 entities) | 14 | $363 |
| Boehringer Ingelheim | 16 | $347 |
| Merck | 13 | $217 |
| Otsuka America Pharmaceutical, Inc. | 8 | $185 |
| Pfizer | 6 | $117 |
| E.r. Squibb & Sons, L.L.C. | 4 | $109 |
| GSK | 6 | $101 |
| Neurocrine Biosciences, Inc. | 3 | $82 |
| Lilly USA, LLC | 4 | $70 |
| Indivior Inc. | 2 | $57 |
| Janssen Products, LP | 2 | $57 |
| Napo Pharmaceuticals Inc | 4 | $56 |
| Clarus Therapeutics Inc. | 5 | $42 |
| Exact Sciences | 1 | $31 |
| Antares Pharma, Inc. | 2 | $27 |
| Lundbeck LLC | 1 | $25 |
| USWM, LLC | 1 | $21 |
| Organon | 1 | $19 |
| Kowa Pharmaceuticals America, Inc. | 1 | $18 |
| Theratechnologies Inc. | 1 | $14 |
| Ironwood Pharmaceuticals, Inc | 1 | $13 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,306 in reported general payments places this provider in the 95th percentile of 4,116 family medicine providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 11 | $324 |
| Gabapentin | 19 | $175 |
| Atorvastatin Calcium | 18 | $170 |
| Metformin Hcl | 19 | $98 |
| Losartan Potassium | 11 | $89 |
| Amlodipine Besylate | 13 | $87 |
| Alcohol SwabsAlcohol Antiseptic Pads | 12 | $70 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Chicago
- Frank PhillipsChicago$1.6M
- Bradley TorphyChicago$1.3M
- Sandy GibsonChicago$309K
- Mandy GittlerChicago$204K
- Igor AltmanChicago$64K
- James DelisChicago$31K
- Tatiana BatistaChicago$26K
- Wen Ho YangChicago$26K
- Abdulmassih AbdulmassihChicago$24K
- Andrew PavlatosChicago$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.